These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26989127)

  • 21. Awake mapping optimizes the extent of resection for low-grade gliomas in eloquent areas.
    De Benedictis A; Moritz-Gasser S; Duffau H
    Neurosurgery; 2010 Jun; 66(6):1074-84; discussion 1084. PubMed ID: 20386138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
    Juratli TA; Schackert G; Krex D
    Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results.
    Berendsen S; Broekman M; Seute T; Snijders T; van Es C; de Vos F; Regli L; Robe P
    Expert Opin Investig Drugs; 2012 Sep; 21(9):1391-415. PubMed ID: 22668241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The sodium pump could constitute a new target to combat glioblastomas].
    Lefranc F; Mijatovic T; Kiss R
    Bull Cancer; 2008 Mar; 95(3):271-81. PubMed ID: 18390407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.
    Porto L; Hattingen E; Stuecher A; Herminghaus S; Lanfermann H; Ulrich Pilatus UP
    J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):147-52. PubMed ID: 22190143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meningeal invasion by gliomas.
    Silverberg GD; Hanbery JW
    J Neurosurg; 1971 Apr; 34(4):549-54. PubMed ID: 4324349
    [No Abstract]   [Full Text] [Related]  

  • 28. Comments and controversies: magnetic resonance spectroscopy and gliomas.
    Fan G
    Cancer Imaging; 2006 Sep; 6(1):113-5. PubMed ID: 16966066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiology: criteria for determining response to treatment and recurrence of high-grade gliomas.
    Lucas J; Zada G
    Neurosurg Clin N Am; 2012 Apr; 23(2):269-76, viii. PubMed ID: 22440870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trial end points in malignant glioma: need for effective trial design strategy.
    Brada M; Yung WK
    Semin Oncol; 2000 Jun; 27(3 Suppl 6):11-9. PubMed ID: 10866345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuroradiological image analysis and prognostic factors of malignant gliomas in the cerebral hemisphere of adults].
    Miyagami M; Kasahara E; Tsubokawa T
    Gan No Rinsho; 1989 Sep; 35(11):1277-88. PubMed ID: 2810774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic performance of texture analysis on MRI in grading cerebral gliomas.
    Skogen K; Schulz A; Dormagen JB; Ganeshan B; Helseth E; Server A
    Eur J Radiol; 2016 Apr; 85(4):824-9. PubMed ID: 26971430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Management of low-grade gliomas].
    Duffau H
    Rev Prat; 2006 Oct; 56(16):1771-7. PubMed ID: 17315502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas.
    Song PJ; Lu QY; Li MY; Li X; Shen F
    J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II study of combined carmustine, 5-fluorouracil, hydroxyurea, and 6-mercaptopurine (BFHM) for the treatment of malignant gliomas.
    Levin VA; Phuphanich S; Liu HC; Da Silva V; Murovic J; Choucair A; Chamberlain M; Berger M; Seager M; Davis RL
    Cancer Treat Rep; 1986 Nov; 70(11):1271-4. PubMed ID: 3021325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biology of gliomas: potential clinical implications of glioma cellular heterogeneity.
    Bigner DD
    Neurosurgery; 1981 Sep; 9(3):320-6. PubMed ID: 6272152
    [No Abstract]   [Full Text] [Related]  

  • 37. Low Grade Gliomas in Children.
    Chalil A; Ramaswamy V
    J Child Neurol; 2016 Mar; 31(4):517-22. PubMed ID: 26286938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Case report of tumors in the area of the foramen magnum].
    Lahl R; Schmidt RM; Grimm E; Mäthner H
    Psychiatr Neurol Med Psychol (Leipz); 1984 Nov; 36(11):678-82. PubMed ID: 6522523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical treatment of brain stem gliomas.
    Lassiter KR; Alexander E; Davis CH; Kelly DL
    J Neurosurg; 1971 Jun; 34(6):719-25. PubMed ID: 4327147
    [No Abstract]   [Full Text] [Related]  

  • 40. Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas.
    van den Bent MJ; Wefel JS; Schiff D; Taphoorn MJ; Jaeckle K; Junck L; Armstrong T; Choucair A; Waldman AD; Gorlia T; Chamberlain M; Baumert BG; Vogelbaum MA; Macdonald DR; Reardon DA; Wen PY; Chang SM; Jacobs AH
    Lancet Oncol; 2011 Jun; 12(6):583-93. PubMed ID: 21474379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.